0
0
Gurugram, India – In a groundbreaking milestone for Indian healthcare, the made-in-India SSI Mantra 3 Surgical Robotic System has successfully performed telesurgeries spanning a distance of 286 kilometers. The surgeries, conducted remotely from Gurugram to Manipal Hospital in Jaipur, mark a significant leap in medical innovation and accessibility.
The first procedure, a Telerobotic-assisted Internal Mammary Artery Harvesting, was performed remotely by Dr. Sudhir Srivastava, Founder, Chairman, and CEO of SS Innovations. Completed in just 58 minutes, the procedure demonstrated remarkable precision with a latency of merely 35–40 milliseconds — a fraction of a second — ensuring seamless execution.
This pioneering surgery was followed by another world-first: a robotic beating-heart Totally Endoscopic Coronary Artery Bypass (TECAB). Known as one of the most complex cardiac procedures, this surgery was also performed via telesurgery between Gurugram and Jaipur, with a similarly low latency of 40 milliseconds.
Transformative Potential for India
Dr. Srivastava highlighted the transformative potential of telesurgery in addressing India’s healthcare disparities. “We are extremely thrilled to have advanced the capabilities of surgery to benefit humanity, especially in areas that need it the most. By enabling telesurgery, we can bridge gaps in access to medical expertise and deliver the highest standard of care, regardless of geographical barriers,” he said.
For a country with a vast rural population and limited access to specialized medical care, this innovation offers a lifeline. It paves the way for advanced medical interventions in remote areas, ensuring timely and accurate treatment for patients.
Dr. Lalit Malik, Chief of Cardiac Surgery at Manipal Hospital, Jaipur, emphasized the practical implications of the innovation. “This groundbreaking inter-state robotic cardiac telesurgery marks a significant leap in enhancing patient care through innovation. The remote robotic-assisted CABG on an elderly patient from Jaipur exemplifies how technology is bridging geographical gaps to provide accurate and timely medical interventions,” he noted.
A Global First for Indian Innovation
Developed by SS Innovations, the SSI Mantra 3 Surgical Robotic System is the first robotic system worldwide to receive regulatory approval for telesurgery and tele-proctoring. Approved by India’s Central Drugs Standard Control Organization (CDSCO), the system is poised to revolutionize healthcare by enabling remote surgeries and facilitating medical education through tele-proctoring.
The system’s success not only cements India’s position as a leader in surgical robotics but also signals a new era of medical accessibility. With its ability to deliver world-class surgical precision across vast distances, the SSI Mantra 3 has the potential to reshape global healthcare delivery.
As technology continues to redefine medical possibilities, these landmark telesurgeries are a testament to India’s growing expertise in leveraging innovation to enhance patient care and bridge healthcare gaps.
